Time-to-infection by Plasmodium falciparum is largely determined by random factors

An Intensive Longitudinal Cohort Study of Malian Children and Adults Reveals No Evidence of Acquired Immunity to Plasmodium falciparum Infection

(2013) Tuan M. Tran et al.   CLINICAL INFECTIOUS DISEASES

Naturally Acquired Antibodies Specific for Plasmodium falciparum Reticulocyte-Binding Protein Homologue 5 Inhibit Parasite Growth and Predict Protection From Malaria

(2013) Tuan M. Tran et al.   JOURNAL OF INFECTIOUS DISEASES

Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria Infection

(2013) Alexander D. Douglas et al.   JOURNAL OF INFECTIOUS DISEASES

Decreased Growth Rate of P. falciparum Blood Stage Parasitemia With Age in a Holoendemic Population

(2013) Mykola Pinkevych et al.   JOURNAL OF INFECTIOUS DISEASES

Humoral and Cellular Immunity to Plasmodium falciparum Merozoite Surface Protein 1 and Protection From Infection With Blood-Stage Parasites

(2013) Ann M. Moormann et al.   JOURNAL OF INFECTIOUS DISEASES

The design and statistical power of treatment re-infection studies of the association between pre-erythrocytic immunity and infection with Plasmodium falciparum

(2013) Michael T White et al.   MALARIA JOURNAL

Relapses Contribute Significantly to the Risk of Plasmodium vivax Infection and Disease in Papua New Guinean Children 1–5 Years of Age

(2012) Inoni Betuela et al.   JOURNAL OF INFECTIOUS DISEASES

Global malaria mortality between 1980 and 2010: a systematic analysis

(2012) Christopher JL Murray et al.   LANCET

The Dynamics of Naturally Acquired Immunity to Plasmodium falciparum Infection

(2012) Mykola Pinkevych et al.   PLoS Computational Biology

Substantially Reduced Pre-patent Parasite Multiplication Rates Are Associated With Naturally Acquired Immunity to Plasmodium falciparum

(2011) A. D. Douglas et al.   JOURNAL OF INFECTIOUS DISEASES

Antibodies to Plasmodium falciparum Antigens Predict a Higher Risk of Malaria But Protection From Symptoms Once Parasitemic

(2011) Bryan Greenhouse et al.   JOURNAL OF INFECTIOUS DISEASES

Adjusting for Heterogeneity of Malaria Transmission in Longitudinal Studies

(2011) T. Bousema et al.   JOURNAL OF INFECTIOUS DISEASES

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children

(2011) Philip Bejon et al.   JOURNAL OF INFECTIOUS DISEASES

Association between Naturally Acquired Antibodies to Erythrocyte‐Binding Antigens ofPlasmodium falciparumand Protection from Malaria and High‐Density Parasitemia

(2010) Jack S. Richards et al.   CLINICAL INFECTIOUS DISEASES

Evidence That the Erythrocyte Invasion Ligand PfRh2 is a Target of Protective Immunity against Plasmodium falciparum Malaria

(2010) L. Reiling et al.   JOURNAL OF IMMUNOLOGY

A quantitative analysis of transmission efficiency versus intensity for malaria

(2010) David L. Smith et al.   Nature Communications

Population Pharmacokinetics of Lumefantrine in Pregnant Women Treated with Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria

(2009) J. Tarning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, Uganda

(2009) J. Mwesigwa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure

(2009) P. Bejon et al.   INFECTION AND IMMUNITY

Understanding the pharmacokinetics of Coartem®

(2009) Abdoulaye Djimdé et al.   MALARIA JOURNAL

Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults

(2008) Arlene E. Dent et al.   PLoS One

A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy

(2008) Rose McGready et al.   PLOS MEDICINE